Trexquant Investment LP Corcept Therapeutics Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$22.21 - $34.48 $1.57 Million - $2.44 Million	-70,851 Reduced 41.32%	100,615 $3.27 Million
Q1 2024 May 14, 2024	BUY	$21.1 - $27.46 $2.34 Million - $3.05 Million	110,948 Added 183.33%	171,466 $4.32 Million
Q4 2023 Feb 09, 2024	SELL	$24.82 - $32.88 $378,604 - $501,551	-15,254 Reduced 20.13%	60,518 $1.97 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $76,477 - $117,657	3,481 Added 4.82%	75,772 $2.06 Million
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $1.55 Million - $1.82 Million	72,291 New	72,291 $1.61 Million
Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $975,894 - $1.47 Million	48,917 Added 285.58%	66,046 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $987,407 - $1.16 Million	-39,976 Reduced 70.0%	17,129 $439,000
Q2 2022 Aug 11, 2022	BUY	$17.33 - $25.3 $46,063 - $67,247	2,658 Added 4.88%	57,105 $1.36 Million
Q1 2022 May 13, 2022	BUY	$16.53 - $25.21 $88,964 - $135,680	5,382 Added 10.97%	54,447 $1.23 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $629,844 - $859,682	36,833 Added 301.12%	49,065 $971,000
Q3 2021 Nov 12, 2021	BUY	$19.68 - $22.53 $240,725 - $275,586	12,232 New	12,232 $241,000
Q4 2020 Feb 11, 2021	SELL	$16.78 - $27.3 $1.04 Million - $1.69 Million	-61,875 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$12.46 - $19.98 $445,382 - $714,185	35,745 Added 136.8%	61,875 $1.08 Million
Q2 2020 Aug 07, 2020	BUY	$11.0 - $18.26 $287,430 - $477,133	26,130 New	26,130 $440,000
Q1 2020 May 08, 2020	SELL	$10.11 - $14.04 $117,356 - $162,976	-11,608 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$12.06 - $16.96 $139,992 - $196,871	11,608 New	11,608 $140,000
Q1 2019 May 13, 2019	SELL	$10.03 - $15.71 $600,476 - $940,526	-59,868 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $510,262 - $776,919	45,196 Added 308.04%	59,868 $800,000
Q3 2018 Nov 09, 2018	SELL	$12.27 - $15.65 $50,515 - $64,431	-4,117 Reduced 21.91%	14,672 $206,000
Q2 2018 Aug 07, 2018	SELL	$15.3 - $19.69 $380,954 - $490,261	-24,899 Reduced 56.99%	18,789 $295,000
Q1 2018 May 03, 2018	BUY	$14.59 - $25.5 $637,407 - $1.11 Million	43,688 New	43,688 $719,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

Black Rock Inc. New York, NY

16.5M
Shares

$850 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$514 Million
0.01% of portfolio
Ingalls & Snyder LLC New York, NY

8.27M
Shares

$425 Million
14.93% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

6.51M
Shares

$335 Million
0.48% of portfolio
Parallel Advisors, LLC

3.81M
Shares

$196 Million
4.22% of portfolio

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account